Thursday, February 26, 2009

FDA Cleared Software Launched by Medical Company

FDA Cleared Software Launched by Medical Company

DataDancer Medical Systems announces the launch of its new FDA Cleared product called "bp Limbo XL". This innovative Stand-Alone blood pressure software is for self monitoring patients.

Chico, CA (PRWEB) February 26, 2009 -- DataDancer Medical Systems, a company specializing in innovative Stand-Alone blood pressure software, launched a new FDA Cleared product called "bp Limbo XL". Michael L. Kohut, president of DataDancer explained; effective treatment for hypertension is best achieved by taking advantage of today's technology in personal blood pressure monitors.

Shifting the responsibility of blood pressure measurement from physician to patient creates a synergistic patient-physician relationship, setting the stage for improved treatment. In the past, patients would visit their physician to assess the efficacy of trial blood pressure treatments from only a few results.

By contrast, "bp Limbo XL" provides the physician and patient with daily blood pressure results that are organized, plotted, averaged, classified and subjected to error-flagging algorithms to improve accuracy. With over fifty million Americans diagnosed with hypertension, "bp Limbo XL" is lowering the bar on hypertension. In the words from the calypso past; "How low can your BP go"!

Visit www.datadancer.com for additional information and free blood pressure log downloads.

"I have white-coat hypertension" said Kohut. "During MD visits, I become anxious and my BP is 30 points higher. This is just one example why home monitoring, in a more relaxed environment, is essential in understanding the true hypertensive state of patients. The fact that patients are becoming involved in the treatment process is a giant leap forward in controlling this disease."

###



Contact Information MICHAEL DE CARO

DataDancer Medical Systems

http://www.datadancer.com

831 685 8482



Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete

Glenwood Systems, LLC Improves Medical Billing Process with GlaceComplete

Glenwood Systems, LLC (http://www.GlenwoodSystems.com) launches the GlaceComplete product suite which seamlessly integrates EMR (http://www.GlaceComplete.com) and Practice Management software (http://www.GlaceComplete.com) to an assisted medical billing process. The product has been designed to reduce the cost associated with clinical and billing inefficiency while maximizing revenue contribution for the average office based medical practice.

Waterbury, CT (Vocus) February 26, 2009 -- Glenwood Systems,LLC announces today the release of GlaceComplete, a combination of software, process and service constructed to improve medical practice revenue and reduce medical practice operation costs. Designed to be affordable via a web based model and to improve revenue in an office based medical practice, GlaceComplete seamlessly integrates easy to use EMR (http://www.GlaceComplete.com) (electronic medical records) and practice management software (http://www.GlaceComplete.com) to a proprietary medical billing process. GlaceComplete simplifies practice workflow, improves offices efficiencies, increases patient file security, frees office space, reduces operational cost and provides new revenue opportunities while maximizing a steady collection of contracted fees billed and the capture of CMS PQRI (http://www.GlaceComplete.com) and e-Prescribing (http://www.GlaceComplete.com) bonus payments.

“Now a physician can have complete oversight and transparency of the medical practice clinical and billing process via the GlaceComplete dashboard and free their staff of the mundane and repetitive administrative and medical billing tasks.” states Nat Loganathan, Founder and CEO Glenwood Systems, LLC “Glenwood is focused on the business health of the practice so the physician can focus on patient health. We are all faced with very tough economic challenges; there is no reason that the average office based physician should let hard earned revenue go unrealized. Many of our clients experience additional bottom line contribution of $20,000 - $50,000 with the use of our proprietary software and assisted medical billing process.”

Glenwood will be presenting the new GlaceComplete program at the ACP Internal Medicine 2009 conference in Philadelphia at the end of April.

Glenwood Systems is best known for its GlaceEMR and Glace Full Service Billing products designed to deliver a complete platform of software and services that encompass all aspects of clinical data management and encounter billing.

To learn more about GlaceComplete visit http://www.glenwoodsystems.com, or contact Ron Flormann.

Glenwood Systems LLC is a privately owned company headquartered in Waterbury, CT with offices in Dayton Ohio, Tampa FL and Orange CA. Founded in 1998 as a provider of technology solution consulting, Glenwood is emerging as a leading provider of web enabled practice management and billing solutions for the healthcare industry. Glenwood Systems is a participant in the EHR Partners Program offered through the American College of Physician’s Center for Practice Improvement and Innovation Participation in this program is available to EHR systems that are certified by the Commission for Healthcare Information Technology Participation in the EHR program does not imply endorsement by ACP or the existence of any type of partnership or representative relationship between Glenwood and ACP

Contact:

Ron Flormann, CCO

Glenwood Systems, LLC

203-437-4089

http://www.glenwoodsystems.com

###



Contact Information Ron Flormann

Glenwood Systems, LLC

http://www.GlenwoodSystems.com

203-437-4089



Wednesday, February 25, 2009

pMDsoft Releases Charge Capture Software for BlackBerry Storm

pMDsoft Releases Charge Capture Software for BlackBerry Storm

pMDsoft, Inc. today extended its popular mobile charge capture and rounding software to the BlackBerry Storm. Combining on-the-go connectivity with the simplicity of a touch interface, this device is a natural evolution for pMDsoft, which emphasizes realtime communication and exceptional ease of use. Practices seeking to save time, recover lost income, and improve patient hand-off can benefit immensely from charge capture; but only if they choose the right solution for their needs.

Long Island City, NY (PRWEB) February 25, 2009 -- pMDsoft Releases Charge Capture Software for BlackBerry Storm

pMDsoft, Inc. today extended its popular mobile charge capture and rounding software (http://www.pmdsoft.com/ChargeCapture/our_solution/blackBerry.html) to the BlackBerry Storm. Combining on-the-go connectivity with the simplicity of a touch interface, this device is a natural evolution for pMDsoft, which emphasizes realtime communication and exceptional ease of use. Practices seeking to save time, recover lost income, and improve patient hand-off can benefit immensely from charge capture; but only if they choose the right solution for their needs.

What's Wrong with Paper?

A paper solution for capturing charges - such as 3x5 index cards, the status quo for tracking hospital patients in many practices - is quick to use and highly mobile. No one can dispute its simplicity. Nonetheless, it exacts hidden tolls in the form of lengthy hand-off conversations, lost or forgotten charges, and delays in reaching the biller. An electronic solution can address these concerns while actually reducing the amount of time that it takes to document each patient encounter; but only if it was designed well for this purpose.

Dr. Jonathan Matthews, of DFW Hospitalists, has realized the benefits of adopting an elegant charge capture solution such as pMDsoft, declaring that "pMDsoft has made our lives a lot simpler, saving me hours of administrative work every week. Now when I leave the hospital, I'm usually done with my billing by the time I get to the car. Information flows easily within my practice, and my life is more efficient - which is more important than ever now that I'm starting to grow my small hospitalist practice." For small practices, great technology can make the difference between prospering and struggling to stay independent.

So what's wrong with paper? It cannot re-use demographics that doctors or staff have previously entered. It cannot help doctors stay abreast of which patients they and their partners have already seen, today or in the distant past. It cannot find its own way to the biller, or be accessed using a Web browser if the doctor forgets to bring it along. And if it is lost or stolen, patients' privacy may suffer.

Fortunately, today's smartphones - capable, friendly devices such as the BlackBerry Storm and the iPhone - have allowed pMDsoft to create a solution that is not only better than the competition; it's also definitely better than paper.

Save Time, Recover Lost Income, and Improve Patient Hand-Off

A practice that is considering adopting mobile charge capture must first determine where its existing process could be improved. In the rush to provide the best patient care or spend time with family, does billing ever fall by the wayside? In this case, the practice stands to tighten its accounts receivables cycle, getting reimbursed more quickly and more reliably for its work. Doctors may also benefit from being able to tell at a glance whom they've seen today and whom they haven't.

On the other hand, the practice's billing might be airtight, up-to-date, and accurate; but the checks and balances that it has put into place to ensure this are consuming it with administrative work. This time could be spent in a more productive way. If this rings true, then the practice stands to recover an immense amount of time by transitioning to a system that cuts out the middle man and sends patient encounters directly to the biller from the point of care. Like Dr. Matthews, the doctors could already be finished with their billing by the time they leave the hospital.

Finally, doctors may be spending a lot of time on the phone with your partners, catching them up on the status of each patient. In this case, the practice may improve both the speed and quality of hand-off (http://www.pmdsoft.com/ChargeCapture/our_solution/blackBerry.html?section=4) by adopting a system that updates highly visible sign-off notes in realtime. Dr. Raj Patcha, of the Huntington Heart Center has found that "I am hardly calling my partners about whom I have to see as it continuously updates itself. It's like my biller is following my clinical rounds. Thanks for making my life easier to run our practice."

pMDsoft retains the best aspects of paper billing, and adds the simplicity of a well-written, truly mobile software solution. Learn more by calling 800-587-4989 or emailing sales (at) pmdsoft (dot) com

About pMDsoft:

Headquartered in New York City, pMDsoft develops wireless applications that help physicians streamline and automate their entire practice from point-of-care through reimbursement. The company was started in 1999 to address physicians' need for an effective, mobile alternative to their paper-based method for recording patient encounters. pMDsoft developed the powerful, flexible, reliable and easy-to-use mobile charge capture solution physicians were seeking. By providing real-time access to patient information anywhere, at any time via handheld devices or desktop computers, pMDsoft's medical billing program enables physicians to automate charge capture; view hospital census and office schedules; create a centralized patient information resource for the practice; and more. Through it all, we protect your patient data by adhering to the highest standards for performance, security and reliability.

Today, pMDsoft's customers include individual physicians, physician practice groups, managed care organizations, hospitals, and billing companies located across the country. We attribute our success to our unwavering commitment to developing the best solution on the market and to our superior 24/7 customer support.

###



Contact Information Philippe d'Offay

pMDsoft, Inc.

http://www.pmdsoft.com/ChargeCapture/

800-587-4989



Tuesday, February 24, 2009

Singapore Offers Hope to Patients with Facial Paralysis

Singapore Offers Hope to Patients with Facial Paralysis

To date, NUH remains the only medical center in the region apart from Australia that possesses the capability of performing the facial reanimation operation. The entire operation costs around US$6,500 and is relatively risk free.

Singapore (PRWEB) February 24, 2009 -- Singapore's willingness to try new and novel ways of performing hitherto complicated surgeries has given a new lease of life to countless hundreds who suffer from facial paralysis (http://www.singaporemedicine.com/healthcaredest/healthcaredest1.asp).

"A paralysis of the face severely hinders a person's ability to engage in social interaction. Even day to day activities like talking may be a problem," says Associate Professor Lim Thiam Chye, Head of the Division of Plastic, Reconstructive and Aesthetic Surgery (http://www.singaporemedicine.com/intl_pts_guide/preparation.asp) at the National University Hospital (NUH).

Such a condition is usually caused by trauma to the brain, cancer or stroke. According to A/P Lim, who also teaches at the National University of Singapore, patients who suffer from paralysis of the face could benefit from a procedure called facial reanimation (http://www.singaporemedicine.com/leadingmedhub/leadingmedhub1.asp).

The surgical process, which was first engineered by Professor Wayne Morrison in Australia about two years ago, is surprisingly simple.

"The traditional method of facial reanimation involved a number of complicated surgeries. Now, patients at NUH are able to undergo a face-lifting procedure to elevate the facial tissues that have dropped down.

"The next step is to harvest a strip of fascia or tendon from the upper thigh. Only about 10cm is required. This works as a sling which is used to connect the facial skin to the temporalis muscle. By giving this muscle an alternative function, we help to reanimate the facial tissues in one single procedure," explains A/P Lim.

Patients will start moving the facial tissues by the end of the first week following surgery, says Dr Ong Wei Chen, a fellow Consultant at NUH.

To date, NUH remains the only medical center (http://www.singaporemedicine.com/hcp/hcp1.asp) in the region apart from Australia that possesses the capability of performing such an operation. The department has been doing about six cases a month for the past one year.

The goal of facial reanimation is basic, yet important. A patient whose face is paralyzed inevitably has a sad appearance, because the face tends to sag. With surgical help, both expression and symmetry can be restored.

"Facial paralysis is a very distressing condition. When half of your face cannot move, simple things that we take for granted become difficult. For example, the eye cannot close and constantly weeps. The mouth dribbles, the speech is interfered with and even a smile becomes difficult. What we try to do is not a matter of aesthetics. We are not making improvements for vanity's sake. We only seek to give the patient back what he or she has lost through some unfortunate circumstances," stresses A/P Lim.

He cautions, however, that while most trauma, brain cancer and stroke patients could potentially benefit from such a procedure, not all of them will be eligible candidates for facial reanimation.

"The thing about it is this - the patient must be very motivated. What we are grafting here is a voluntary muscle. Unlike the gut for example, which is involuntary and works without you having to consciously tell it to, this procedure works only if the patient consciously activates the muscle, especially in the first few months after surgery."

A/P Lim advises his patients to "practice smiling" in front of the mirror regularly, until such time when the act comes naturally and easily.

"The facial sling basically helps to pull the corner of the mouth upwards, resulting in a smile of sorts. This is achieved when the patient bites down on his teeth," he explains.

The entire facial reanimation operation costs around US$6,500 (http://www.singaporemedicine.com/healthcaredest/sg.asp) and is relatively risk free. Most patients would not need hospitalization beyond a couple of days.

"People whose faces are paralyzed are virtually social cripples. They are unwilling and even ashamed to go out or attend social functions. Hopefully, this procedure will restore their confidence and their social life," he says.

About the National University Hospital (NUH)

NUH is a specialist hospital that provides advanced, leading-edge medical care. Equipped with state-of-the-art facilities as well as dedicated and well-trained staff, NUH is a major referral centre that delivers tertiary care for a wide range of medical specialties. In 2004, NUH became the first Singapore hospital to receive accreditation by the Joint Commission International (JCI), an international stamp for excellent clinical practices in patient care and safety. It was also the first hospital in Singapore to receive a triple ISO certification concurrently for Quality, Environmental, and Occupational Health & Safety Management Systems. (www.nuh.com.sg)

About the NUH Aesthetic Plastic Surgery Center

The NUH Aesthetic Plastic Surgery Center (http://www.singaporemedicine.com/hcp/intl_pts_svcs_ctr.asp) is a one-stop clinic providing comprehensive and customized aesthetics and medical treatments for patients suffering from any medical or surgical conditions affecting the face and body. The Center seeks to help individuals find solutions for their cosmetic concerns using surgical or non-invasive surgical methods.

About SingaporeMedicine

Launched in 2003, SingaporeMedicine is a multi-agency government-industry partnership committed to strengthening Singapore's position as Asia's leading medical hub and international health care destination (http://www.singaporemedicine.com/). Led by the Ministry of Health of Singapore, SingaporeMedicine is supported by three government agencies: the Economic Development Board, which develops industry capabilities, the International Enterprise Singapore, which fosters regionalism by Singapore-based health care players, and the Singapore Tourism Board, which markets Singapore as a healthcare destination to inbound international patients and develops associated people-oriented services. (www.singaporemedicine.com)

###



Contact Information Felicia Tan

Singapore Tourism Board - Singapore Medicine

http://www.singaporemedicine.com/

+65 6831-3505



Monday, February 23, 2009

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

Ugandan Children Receive Life-Saving Treatment For Heart Defects At Children's National Medical Center

Through partnership with Samaritan's Purse and Gift of Life, patients travel to United States **Media Note: Patients will be at Children's National for farewell visit on Tuesday, February 24**

Washington, DC --On February 12, two Ugandan children received life-saving procedures at Children's National Medical Center (http://www.childrensnational.org/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) to correct severe heart defects. Without cardiac surgery, the young boys would likely have died before adulthood, but they now have a normal life expectancy.

As part of the Phase I of a global initiative to bring attention to the health needs of Ugandan children, 15-month-old Daniel Kamaramasu and 2 ½-year-old Allan Wassanyi traveled 5,000 miles to receive treatment unavailable at home. Daniel, who was born with a blocked valve between his heart and lungs, was successfully treated using a cardiac catheterization balloon procedure by Michael Slack, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=470&Name=Michael%20Slack?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda). Allan, who had a very large hole in his heart, underwent successful open heart surgery by Richard Jonas, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocID=1195&Name=Richard%20Jonas?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda).

The boys came to Children's National through a partnership with international relief organization Samaritan's Purse, Gift of Life International (GOLI), and other organizations. Through this partnership, pediatric cardiologist Craig Sable, MD (http://www.childrensnational.org/FindADoctor/Doctor_Marqui.aspx?DocId=424&Name=Craig%20Sable?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda) has led seven medical missions to Uganda in an effort to provide treatment for patients and ultimately build a sustainable cardiac surgery program in Uganda. More than 100 children have received life-saving treatment since the program began in 2003.

"With the dedication of organizations like Samaritan's Purse and Gift of Life, patients from around the world have access to the expert pediatric care that is available to children in the United States," said Dr. Sable.

Added Cindy Bonsall, director of Samaritan's Purse's Children's Heart Project: "We're glad this partnership has enabled so many Ugandan children to receive the cardiac care they deserve. We're glad they will be returning home soon with a second chance at life."

A key component of the missions to Uganda has been training Ugandan surgeons. Through training provided by Dr. Sable and colleagues, Ugandan surgeons are now on the verge of doing simple cardiac procedures on their own. Dr. Sable directs the Telemedicine Program at Children's National, which provides training and educational opportunities around the world.

The groups have joined forces to implement "Our Hearts Are In Uganda," which will focus all of GOLI's efforts in Uganda. The first phase of the program included treatment for Daniel, Allan, and three other children at hospitals in the United States. The next phase will bring 25 more Ugandan children to hospitals throughout the world to receive life-saving treatment for heart defects.

"We have saved the lives of more than 10,000 children, and through this partnership, we hope to expand our reach, to ultimately create a program in Uganda to ensure that all the children have access to the medical care they need," said Lou del Rosario, vice chairman of GOL District 7230, who was instrumental in raising funds for Allan's operation.

MEDIA NOTE: The patients will be returning to Children's National for a farewell visit on Tuesday, February 24. The patients and Dr. Craig Sable will be available for interviews. Contact Emily Dammeyer or Jenn Leischer at 202-476-4500.

About Children's National Medical Center (http://www.childrensnational.org/about/?utm_source=pressrelease&utm_medium=2_23&utm_campaign=uganda)

Children's National Medical Center, located in Washington, DC, is a proven leader in the development of innovative new treatments for childhood illness and injury. Children's has been serving the nation's children for more than 135 years. Children's National is proudly ranked among the best pediatric hospitals in America by US News & World Report and the Leapfrog Group. For more information, visit www.childrensnational.org.

About Samaritan's Purse

Samaritan's Purse identifies children needing life-saving heart treatment through its' Children's Heart Project. The international relief organization identifies children overseas who need heart surgery, matches them with hospitals and specialists willing to donate their time and services, places them with a local host family, and arranges international travel and an interpreter. More than 550 children from nine countries have been brought to North America for medical and surgical care not available in their home countries.

About Gift of Life International

Gift of Life is a Rotary based program in more than 50 Rotary Clubs and Districts on 6 continents. GOLI aims to save as many children's lives as possible by providing life saving open heart surgery to children from infancy to 18 years of age with congenital heart defects. GOLI has been responsible for saving more than 10,000 lives during the past 33 years.

###



Contact Information Emily Dammeyer

Children's National Medical Center

http://www.childrensnational.org

202-476-4500



iCardiac Reports Significant Revenue Growth and Profitability

iCardiac Reports Significant Revenue Growth and Profitability

iCardiac Continues to Successfully Leverage Differentiated Service and Product Offering

Rochester, New York (PRWEB) February 23, 2009 -- iCardiac Technologies, Inc., a leading innovator in advanced cardiac safety biomakers and automated QT analysis, today announced that the company has experienced significant revenue growth as its quarter over quarter revenues have grown in excess of 100%. Pharmaceutical and biotechnology companies continue to select iCardiac as a critical provider for their cardiac safety studies because of the company's scientific expertise, project management capabilities, as well as the industry's most advanced ECG analysis methodologies, which can both dramatically reduce the cost of cardiac safety studies in addition to reducing the likelihood of false-positives. Additionally, as iCardiac's revenues have continued to increase, the company achieved profitability in the last quarter of 2008.

iCardiac continues to advance the field of cardiac safety in Phase I, II, III as well as TQT studies through its end-to-end offering of cardiac safety analysis services. During 2009, iCardiac will aggressively continue to bring to market its Highly Automated QT(sm) and QT beat-to-beat offerings.

"To date our highly automated technology has been applied in over 10 clinical QT data analyses," said Sasha Latypova, Executive Vice President at iCardiac Technologies. "Pharmaceutical companies are gaining more accurate results and are substantially lowering the cost per Thorough QT study."

The drive to greater automation of the cardiac safety analysis process stems from general dissatisfaction in the industry regarding "gold standard" manual measurements that are both time-consuming and expensive. iCardiac's highly automated QT technology is different from "fully automated" approaches - which are based solely on computers - because it combines advanced ECG signal processing algorithms, developed over the past decade, with a robust quality assurance process conducted by cardiologists.

The technology performs a precise automated QT measurement and, using sophisticated statistical models and algorithms, guides cardiologists to those ECGs that require attention. It produces significant cost savings because only a portion of the entire Thorough QT dataset requires manual over-reading.

Highly Automated QT analysis is part of iCardiac's software platform COMPAS 3.0, originally developed at the University of Rochester Heart Research Follow-Up Program, the international leader in electrophysiology research and the study of the congenital Long QT Syndrome. The platform provides comprehensive analysis of cardiac repolarization signals and contains several advanced arrhythmia biomarkers, as well as advanced ECG signal processing tools. COMPAS serves as the core technology behind the leading cardiac safety analysis services that iCardiac provides to pharmaceutical, biotech companies and clinical research organizations.

About iCardiac Technologies

iCardiac Technonogies, Inc. is a technologically differentiated cardiac core lab providing expert scientific consultation, end-to-end project management, statistical analysis and the industry's most sophisticated FDA-accepted cardiac safety assessment methodologies. iCardiac's analysis service provides drug developers with more precise and cost-effective methods for QT interval measurement, including Highly Automated QT, which has been validated by pharmaceutical companies and accepted by the FDA as equivalent to the manual evaluation of ECGs in Thorough QT studies. In addition, iCardiac provides Beyond QT, a suite of advanced ECG-based cardiac safety markers that have been accepted as secondary end-points by the regulators, and deliver a more accurate assessment of the cardiac safety profile of drugs in development. iCardiac's COMPAS technology has been used for over a decade in cardiac clinical trials conducted for and by leading large and medium sized pharmaceutical, biotechnology, and medical device companies. For more information, visit: www.icardiac.com.

###



Contact Information Sasha Latypova

iCardiac Technologies, Inc.

http://www.icardiac.com

585-295-7610 (103)



Thursday, February 19, 2009

Global Ventricular Assist Devices Market to reach $1.2 Billion by 2014, According to New Report by Global Industry Analysts, Inc.

Global Ventricular Assist Devices Market to reach $1.2 Billion by 2014, According to New Report by Global Industry Analysts, Inc.

Driven by enhanced focus on development of next generation devices, and widening demand and supply gap for heart transplantation, the global market for ventricular assist devices is projected to exceed $1.2 billion by 2014.

San Jose, CA (PRWEB) February 19, 2009 -- Globally, about one million people suffer from end-stage heart failure. With demand for heart transplantation, the traditional procedure for end-stage heart failure, surpassing the availability of donor hearts, use of ventricular assist devices (VADs) has emerged as an ideal alternative form of treatment for such patients. Development of VADs with improved design, features and durability is expected to expand its adoption across a broader patient population, including women and children.

Besides, the arrival of second generation and third generation VADs has expanded the scope of using destination therapy as an early intervention measure in the treatment of heart failure, thereby offering hope to several heart failure patients. Destination Therapy holds vast potential in the overall ventricular assist devices (VAD) (http://www.strategyr.com/Ventricular_Assist_Devices_Market_Report.asp) market, driven primarily by the benefits of procedure when compared to conventional heart transplantations. Further, the procedure holds promise owing to its use among patients who are otherwise ineligible for donor hearts due to old age or severe sickness.

United States represents the largest market for VADs, as stated in a recent report by Global Industry Analysts, Inc. A major driver for the use of VADs in United States is the recommendation by various medical associations for using alternative therapies (including VADs) in the treatment of advanced stage cardiac failure patients. The adoption of VADs is also affected by factors such as cost of device, competition from drug industry, reimbursement levels, and time period for gaining FDA approvals.

Thoratec Corporation is the predominant player with about 50% share of the global VAD market. Other key players operating in the market include Abiomed Inc., Berlin Heart GmbH, EvaHeart Medical USA Inc., Jarvik Heart Inc., MicroMed Cardiovascular Inc., SynCardia Systems Inc., Terumo Heart Inc., Ventracor Limited, and World Heart Corporation.

The report titled "Ventricular Assist Devices: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a review of market dynamics, trends, issues, and competition pertaining to the market. The report enumerates recent product introductions/innovations, developments, mergers, acquisitions and other strategic industry activities. Analysis is presented for the period 2005-2015 for United States, Europe, and Rest of World.

For more details about this research report, please visit

http://www.strategyr.com/Ventricular_Assist_Devices_Market_Report.asp

About Global Industry Analysts, Inc.

Global Industry Analysts, Inc., (GIA) (http://www.strategyr.com) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs more than 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of more than 60,000 smaller research products including company reports, market trend reports and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.

Telephone 408-528-9966

Fax 408-528-9977

Web Site http://www.StrategyR.com

###



Contact Information Public Relations

Global Industry Analysts, Inc.

http://www.StrategyR.com/

(408) 528-9966



Landmark Trial Provides Vital Information for Cardiac Disease Treatment

Landmark Trial Provides Vital Information for Cardiac Disease Treatment

NorthShore University HealthSystem Ted Feldman, M.D., Lead Investigator

Evanston, IL. -- NorthShore University HealthSystem (http://www.northshore.org/) (NorthShore) has played a leading role in a landmark clinical trial comparing two forms of treatment for patients with severe coronary artery disease (CAD). The results were published on-line in this week's issue of the New England Journal of Medicine.

The SYNTAX trial was a clinical research study that compared percutaneous coronary intervention (PCI) with drug-eluting stents and coronary artery bypass surgery (CABG) in patients with three-vessel and left main coronary disease. The trial results did not show any statistically significant differences between PCI and CABG in rates of death or heart attack, an excess of stroke in the CABG treated patients, and a greater need for repeat PCI procedures in the stent treated patients. These are better outcomes for PCI than have been seen in prior trials in less complex patients.

"At NorthShore, we experienced stunning outcomes in patients whose only option would have previously been bypass surgery," said Ted Feldman, M.D, F.S.C.A.I., Director of Cardiac Catheterization Laboratory, NorthShore University HealthSystem, and a lead investigator of the trial. "The data in this study will provide cardiologists with additional information as they determine treatment therapy for patients with complex CAD."

The trial is the first randomized, controlled clinical trial to compare these two treatments in patients with left main disease and/or three-vessel disease, who are typically treated with CABG and represent a population with far more complex anatomy and advanced disease than those studied in prior drug-eluting stent (DES) clinical trials.

There were 1,800 patients enrolled in the randomized arm of the trial. All patients were assessed by a multidisciplinary team including an interventional cardiologist and a cardiac surgeon. If both the cardiologist and surgeon felt that they could offer equivalent complete revascularization, patients were randomized 1:1 into one of the two treatment strategies. If either the cardiologist or surgeon felt that one or the other revascularization technique was the preferred option, due to technical considerations or co-morbidity, for example, then patients were recruited into one of two parallel, nested registries for PCI or CABG. Thus, patients in the PCI registry had been rejected for cardiac surgery.

About NorthShore University HealthSystem

Headquartered in Evanston, Ill., NorthShore University HealthSystem (NorthShore) is a comprehensive, fully integrated, healthcare delivery system that serves the greater North Shore and northern Illinois communities. The system includes three Hospitals--Evanston Hospital, Glenbrook Hospital and Highland Park Hospital--and a fourth, Skokie-based Rush North Shore Hospital, to be added in January 2009. In addition, the healthsystem has more than 2,000 affiliated physicians, including a 550-physician, multispecialty physician group practice with over 70 office locations-- NorthShore University HealthSystem Medical Group. Further, NorthShore is committed to excellence in its academic mission and supports teaching and research as the principal teaching affiliate of the University of Chicago's Pritzker School of Medicine. The NorthShore University HealthSystem Research Institute, with more than $100 million of grants, focuses on clinical and translational research, including leadership in outcomes research and clinical trials.

NorthShore has annual revenues of $1.5 billion and a staff of more than 8,000. The healthsystem has significant capabilities in a wide spectrum of clinical programs, including cancer, heart, orthopaedics, high-risk maternity and pediatrics. NorthShore is a national leader in the implementation of innovative technologies, including electronic medical records, (EMR ). In 2003, the healthsystem was among the first in the country to successfully launch a systemwide EMR with demonstrable benefits in quality, safety, efficiency and service to patients. NorthShore has been recognized by multiple national organizations for this notable achievement. Visit http://www.northshore.org/

CONTACT: Amy Ferguson

Senior Director, Public Relations

NorthShore University HealthSystem

(847) 570-3146

###



Contact Information Amy Ferguson

Northshore University HealthSystem

http://www.northshore.org/

847-570-3146